A microfluidic platform for cultivating ovarian cancer spheroids and testing their responses to chemotherapies N Dadgar, AM Gonzalez-Suarez, P Fattahi, X Hou, JS Weroha, ... Microsystems & nanoengineering 6 (1), 93, 2020 | 66 | 2020 |
Study of toxicity effect of pegylated nanoliposomal artemisinin on breast cancer cell line N Dadgar, SE Alavi, MKM Esfahani, A Akbarzadeh Indian Journal of Clinical Biochemistry 28, 410-412, 2013 | 31 | 2013 |
Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer N Dadgar, MKM Esfahani, S Torabi, SE Alavi, A Akbarzadeh Indian journal of clinical biochemistry 29 (4), 501-504, 2014 | 24 | 2014 |
Cartilage tissue engineering using injectable functionalized Demineralized Bone Matrix scaffold with glucosamine in PVA carrier, cultured in microbioreactor prior to study in … N Dadgar, A Ghiaseddin, S Irani, S Rabbani, SHA Tafti, M Soufizomorrod, ... Materials Science and Engineering: C 120, 111677, 2021 | 17 | 2021 |
Microfluidic confinement enhances phenotype and function of hepatocyte spheroids JH Choi, L Loarca, JM De Hoyos-Vega, N Dadgar, K Loutherback, ... American Journal of Physiology-Cell Physiology 319 (3), C552-C560, 2020 | 17 | 2020 |
Bioartificial injectable cartilage implants from demineralized bone matrix/PVA and related studies in rabbit animal model N Dadgar, A Ghiaseddin, S Irani, SHA Tafti, M Soufi-Zomorrod, ... Journal of biomaterials applications 35 (10), 1315-1326, 2021 | 16 | 2021 |
Modeling and prediction of cytotoxicity of artemisinin for treatment of the breast cancer by using artificial neural networks A Qaderi, N Dadgar, H Mansouri, SE Alavi, M Koohi Moftakhari Esfahani, ... Springerplus 2, 1-5, 2013 | 16 | 2013 |
Effect of artemisinin liposome and artemisinin liposome polyethyleneglycol on MCF-7 cell line D Neda, N Dariush, C Mohsen, ES Hassan, MS Mohammadreza, F Ali, ... Int. J. Life Sci. Biotechnol. Pharm. Res 2, 349-355, 2013 | 14 | 2013 |
Evaluation the cytotoxicity of nanoliposomal artemisinin on breast cancer cell line N Dadgar, SE Alavi, MEM KOOHI, M Chiani, S Torabi, A Akbarzadeh NEW CELLULAR & MOLECULAR BIOTECHNOLOGY JOURNAL 4 (13), 99-103, 2014 | 13* | 2014 |
A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow–Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn’s Disease AL Lightner, J Reese, J Ream, D Nachand, X Jia, N Dadgar, SR Steele, ... Diseases of the Colon & Rectum 66 (10), 1359-1372, 2023 | 11 | 2023 |
Decellularized human amniotic membrane reinforced by MoS2-Polycaprolactone nanofibers, a novel conductive scaffold for cardiac tissue engineering H Nazari, A Heirani-Tabasi, E Esmaeili, AM Kajbafzadeh, Z Hassannejad, ... Journal of Biomaterials Applications 36 (9), 1527-1539, 2022 | 11 | 2022 |
Adipose tissue‐derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease J Altemus, N Dadgar, Y Li, AL Lightner Journal of Cellular Physiology 237 (7), 3001-3011, 2022 | 10 | 2022 |
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming W Mohammed Ismail, A Mazzone, FG Ghiraldini, J Kaur, M Bains, ... Communications Biology 6 (1), 215, 2023 | 7 | 2023 |
A phase IB/IIA study of allogeneic, bone marrow-derived, mesenchymal stem cells for the treatment of refractory ileal-anal anastomosis and peripouch fistulas in the setting of … AL Lightner, J Reese, J Ream, D Nachand, X Jia, AO Pineiro, N Dadgar, ... Journal of Crohn's and Colitis 17 (4), 480-488, 2023 | 6 | 2023 |
A phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim … AL Lightner, N Dadgar, C Matyas, K Elliott, C Fulmer, N Khaitan, J Ream, ... Colorectal Disease 24 (11), 1358-1370, 2022 | 6 | 2022 |
Cold atmosphere plasma modification on Beta-carotene-loaded nanofibers to enhance osteogenic differentiation Y Moradi, SA Atyabi, A Ghiassadin, H Bakhshi, S Irani, SM Atyabi, ... Fibers and Polymers, 1-10, 2021 | 6 | 2021 |
Characterizing the immune environment in peritoneal carcinomatosis: insights for novel immunotherapy strategies PL Wagner, CM Knotts, VS Donneberg, N Dadgar, CC Pico, K Xiao, ... Annals of Surgical Oncology 31 (3), 2069-2077, 2024 | 5 | 2024 |
Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T‐cell immunosuppressive capacity N Dadgar, J Altemus, Y Li, AL Lightner Journal of Cellular and Molecular Medicine 26 (19), 4924-4939, 2022 | 5 | 2022 |
A phase IB/IIA study of ex vivo expanded allogeneic bone marrow–derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn’s disease AL Lightner, JS Reese, J Ream, D Nachand, N Dadgar, A Adams, ... Surgery 175 (2), 242-249, 2024 | 4 | 2024 |
Mesenchymal stem cell extracellular vesicles as a new treatment paradigm in solid abdominal organ transplantation: a case series AL Lightner, M Fujiki, M Elshawy, N Dadgar, A Barnoski, M Osman, ... Stem Cells and Development 33 (5-6), 107-116, 2024 | 2 | 2024 |